Doug Given

Doug Given

Signal active

Managing Partner

Bio

Currently, Doug is CEO at Health2047 and managing partner at G5 Partners. He also participates on the board of directors of both public and private companies, currently serving as chairman of the board at both Arrowhead Research (NASDAQ: ARWR) and Vivaldi Biosciences. Doug has advised VC funds in Australia, US and Israel, and has served as an investment professional and general partner on more than 45 investments at Bay City Capital, a Silicon Valley-based venture capital firm focused on life sciences.

Over his career, Doug has directly participated in the development of more than 15 top-selling drugs, biologics, diagnostics, imaging agents, and medical devices. He has overseen the product development process at Schering Plough Research, Monsanto/G.D. Searle Research Laboratories, and Lilly Research Laboratories and as Sr VP and CTO at Mallinckrodt. At the Pharmaceutical Manufacturer's Association, Doug chaired the Combined Regulatory Affairs Committee and was a founding board member of the International Conference on Harmonization and member, US Japan Business Council.

Doug has also led large teams through high growth, IPO, M&A, restructuring and exit processes as a C-level executive and board director. He has served as a director and CEO of Progenitor, NeoRX, VIA Pharmaceuticals and Vivaldi Biosciences and as a Director of Aksys Inc, Sembiosys Genetics Inc and numerous additional private company boards.

Doug retains strong ties to world-class academic institutions. He is an advisor to the University of Chicago Medicine and the Pritzker School of Medicine, where he received the distinguished alumnus award in 2011. Doug is also an advisor to the Harvard School of Public Health and the Johns Hopkins Bloomberg School of Public Health. He is a frequent speaker at leading business, private equity and life science conferences, including the Wharton Economic Summit, the American Medical Association, and the World Vaccine Congress and the NanoGagliato Conference.

Location

San Francisco, California, United States, North America

Social

Primary Organization

Health2047

Health2047

Founded

2015

Investment

6

Lead investment

2

Exits

0

Employees

11-50

Industry

Health Care, Wellness, Hospital

Jobs history

1

Health2047

Managing Partner

2018 - Current

Board and Advisor Roles

0

N/A

Invest in regions

Profile Resume

Doug Given is the Managing Partner at Health2047, based in United States, North America. With a background in Health Care, Doug Given has a rich history of leadership and innovation. Doug Given studied MD Medicine and Virology @ Pritzker School of Medicine. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.

Recommendation from your interest

N/A

Investment portfolio

N/A

Number of investment

1

Number of exits

0

Personal investment

0

There is no personal investment available on this profile

Partner investment

3

Annouced DateOrganization NameFunding RoundInvestor NameMoney Raised
Jan 21, 2009
Vivaldi Biosciences Vivaldi Biosciences
Series A - Vivaldi Biosciences
Vivaldi Biosciences Bay City Capital
23.0M
Jul 12, 2021
Bayesian Health Bayesian Health
Venture Round - Bayesian Health
-15.0M
Feb 10, 2022
AndHealth AndHealth
Seed Round - AndHealth
-57.0M

Exits

0

There is no exit available on this Profile

Invest in industries

Recent Activity

There is no recent news or activity for this profile.